Allied Corp. , an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues, is pleased to announce the submission of a confirmation of readiness package (the “Readiness Package”) to Health Canada for a cultivation license at its new facility in Kelowna, BC. The Readiness Package was submitted by Allied’s wholly owned subsidiary, Falcon Ridge Inc., a Canadian Licensed Producer applicant.
Submission of the Readiness Package represents the last stage of review and approval before being granted the License to Cultivate cannabis under the Canadian Cannabis Regulations. When granted, the License to Cultivate enables the license holder to be able to sell wholesale product to other LPs (Licensed Producers) and import/export to and from domestic and international LPs. Prior to submitting the Readiness Package, Allied completed the in depth review requirements necessary for advancing towards the License to Cultivate. Some of these requirements included creating Standard Operating Procedure Report, Security Master Plan Report, Organizational Security Plan Report, Good Production Practices Report and a video of the new building facility.
The new purpose built 9,000 square foot cultivation facility was designed and constructed based upon current GMP (Good Manufacturing Practices) requirements. The building has rooms for custom breeding of novel genetics and cannabis flowering rooms, as well as a large scientific area that is dedicated to cannabinoid extraction and end product fulfillment.
Along with the new facility in Kelowna, Allied continues to advance towards the first commercial harvest in Colombia.
“We are excited to enter into the last licensing step necessary in order to receive the license to cultivate in Canada,” said Calum Hughes, CEO of Allied. “This is a significant accomplishment for our operation in Canada and an important part of our international supply chain.”
For more information on Allied Corp., visit www.allied.health
About Allied Corp.
Allied Corp. is an international medical cannabis production company with a mission to address today’s medical issues by researching, creating and producing targeted cannabinoid health solutions. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.
Investor Relations:
ir@allied.health
1-877-255-4337